Ketoacid analogues in patients with chronic kidney disease.

dc.contributor.authorMartínez-Pizarro, Sandra
dc.date.accessioned2025-01-07T12:43:25Z
dc.date.available2025-01-07T12:43:25Z
dc.date.issued2020-08-15
dc.identifier.doi10.1016/j.nefro.2020.05.011
dc.identifier.essn2013-2514
dc.identifier.pmid32807577
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.nefro.2020.05.011
dc.identifier.urihttps://hdl.handle.net/10668/24877
dc.issue.number3
dc.journal.titleNefrologia
dc.journal.titleabbreviationNefrologia (Engl Ed)
dc.language.isoen
dc.language.isoes
dc.organizationSAS - Hospital La Inmaculada
dc.page.number359-360
dc.pubmedtypeLetter
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.meshDietary Supplements
dc.subject.meshHumans
dc.subject.meshKeto Acids
dc.subject.meshRenal Insufficiency, Chronic
dc.titleKetoacid analogues in patients with chronic kidney disease.
dc.title.alternativeAnálogos de cetoácidos en pacientes con enfermedad renal crónica.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number41

Files